Cargando…
In Vivo and In Vitro Characterization of the Recently Emergent PRRSV 1-4-4 L1C Variant (L1C.5) in Comparison with Other PRRSV-2 Lineage 1 Isolates
The recently emerged PRRSV 1-4-4 L1C variant (L1C.5) was in vivo and in vitro characterized in this study in comparison with three other contemporary 1-4-4 isolates (L1C.1, L1A, and L1H) and one 1-7-4 L1A isolate. Seventy-two 3-week-old PRRSV-naive pigs were divided into six groups with twelve pigs/...
Autores principales: | Rawal, Gaurav, Almeida, Marcelo N., Gauger, Phillip C., Zimmerman, Jeffrey J., Ye, Fangshu, Rademacher, Christopher J., Armenta Leyva, Betsy, Munguia-Ramirez, Berenice, Tarasiuk, Grzegorz, Schumacher, Loni L., Aljets, Ethan K., Thomas, Joseph T., Zhu, Jin-Hui, Trexel, Jolie B., Zhang, Jianqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674456/ https://www.ncbi.nlm.nih.gov/pubmed/38005910 http://dx.doi.org/10.3390/v15112233 |
Ejemplares similares
-
Development, Evaluation, and Clinical Application of PRRSV-2 Vaccine-like Real-Time RT-PCR Assays
por: Rawal, Gaurav, et al.
Publicado: (2023) -
Comparative evaluation of 4 commercial modified‐live porcine reproductive and respiratory syndrome virus (PRRSV) vaccines against heterologous dual Korean PRRSV‐1 and PRRSV‐2 challenge
por: Oh, Taehwan, et al.
Publicado: (2020) -
In Situ Hybridization of PRRSV-1 Combined with Digital Image Analysis in Lung Tissues of Pigs Challenged with PRRSV-1
por: Dénes, Lilla, et al.
Publicado: (2021) -
A Novel Motif in the 3′-UTR of PRRSV-2 Is Critical for Viral Multiplication and Contributes to Enhanced Replication Ability of Highly Pathogenic or L1 PRRSV
por: Xiong, Junyao, et al.
Publicado: (2022) -
Implementing a user‐friendly format to analyze PRRSV next‐generation sequencing results and associating breeding herd production performance with number of PRRSV strains and recombination events
por: Trevisan, Giovani, et al.
Publicado: (2022)